Patrick Twomey

Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE).

Delvys Rodríguez‐Abreu, Melissa L. Johnson, Maen Hussein et al. · Journal of Clinical Oncology · 2020 · 240 citations

Pd-l1-selected Nsclc, Immunology, Immunoediting +20

Respiratory gas tensions and pH in healing wounds

Thomas K. Hunt, Patrick Twomey, B Zederfeldt et al. · The American Journal of Surgery · 1967 · 232 citations

Sepsis, Pulmonary Physiology, Wound Care +3

Comparison of nutritional indices and outcome in critically ill patients

Keith N. Apelgren, John L. Rombeau, Patrick Twomey et al. · Critical Care Medicine · 1982 · 151 citations

Nutrition, Prognosis, Body Composition +18

Serum Albumin and Body Weight as Predictors of Postoperative Course in Colorectal Cancer

Donn M. Hickman, Rebecca Miller, John L. Rombeau et al. · Journal of Parenteral and Enteral Nutrition · 1980 · 129 citations

Nutrition, Bariatric Surgery, Surgical Oncology +16

Cellular immunity in cured cancer patients

Patrick Twomey, William J. Catàlona, Paul B. Chretien · Cancer · 1974 · 100 citations

Immunology, Immunoediting, Pathology +17